Results 91 to 100 of about 62,670 (227)

Mortiers de toutes sortes

open access: yesRevue d'histoire de la pharmacie, 1971
Mortiers de toutes sortes. In: Revue d'histoire de la pharmacie, 59ᵉ année, n°209, 1971. pp. 405-408.
openaire   +2 more sources

Nivolumab in previously untreated melanoma without BRAF mutation.

open access: yesNew England Journal of Medicine, 2015
C. Robert   +27 more
semanticscholar   +1 more source

Durabilité d’un ciment composé à base de mâchefer de Tefereyre (Niger): absorption capillaire, porosité accessible à l’eau et attaque acide

open access: yesJournal of Materials and Engineering Structures, 2016
Dans la présente étude, nous évaluons les caractéristiques vis-à-vis de la durabilité d’un ciment composé à base de mâchefer de charbon produit par la SONICHAR (Société Nigérienne de production d’énergie à base de  charbon minéral).
Nafissatou SAVADOGO   +4 more
doaj  

Empowering newcomers? Power asymmetries and negotiations between newly arrived migrants and volunteers within buddy programmes

open access: yesInternational Journal of Evidence Based Coaching and Mentoring
Research on buddy programmes for newly arrived migrants focuses predominantly on integration outcomes. However, the intervention is also prone to reproducing power imbalances.
Gaëlle Mortier   +2 more
doaj   +1 more source

ThinkAir: Dynamic resource allocation and parallel execution in the cloud for mobile code offloading

open access: yes2012 Proceedings IEEE INFOCOM, 2012
Sokol Kosta   +4 more
semanticscholar   +1 more source

Mental disorders among college students in the World Health Organization World Mental Health Surveys

open access: yesPsychological Medicine, 2016
R. P. Auerbach   +35 more
semanticscholar   +1 more source

Improved overall survival in melanoma with combined dabrafenib and trametinib.

open access: yesNew England Journal of Medicine, 2015
C. Robert   +26 more
semanticscholar   +1 more source

Roland Mortier [PDF]

open access: yesRecherches sur Diderot et sur l'Encyclopédie, 2015
openaire   +2 more sources

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

open access: yesNew England Journal of Medicine, 2017
J. Weber   +33 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy